Invasive und nichtinvasive Diagnostik der Hypovolämie bei akuter Pankreatitis

Zusammenfassung

Die akute Pankreatitis ist bei schwerem Verlauf mit einem ausgeprägten intraperitonealen Flüssigkeitsverlust verbunden, welcher zu einem Volumenmangelschock führen kann. Die Sequestration von Flüssigkeit kann bis zu 40 Prozent des zirkulierenden Blutvolumens betragen. Die Menge der erforderlichen Flüssigkeits- und Elektrolytersatztherapie wird daher häufig deutlich unterschätzt, was sich auf die Rate der Organkomplikationen und die Gesamtmortalität der Erkrankung auswirkt. Außerdem scheint eine rasche und adäquate Volumentherapie durch Verbesserung der Organperfusion und Oxygenierung des Pankreas den prognostischen Verlauf einer akuten Pankreatitis zu beeinflussen. Auf der anderen Seite droht vor allem bei kardialen und pulmonalen Komorbiditäten eine Volumenüberladung mit daraus resultierender kardiopulmonaler Dekompensation. Dies macht die sorgfältige Bilanzierung und engmaschige Kontrolle der hämodynamischen Parameter, bei schwerem Verlauf der Erkrankung unter intensivmedizinischen Bedingungen, zu einem wichtigen Bestandteil der Therapie. Im klinischen Alltag wird der dominierende Anteil der Patienten mit akuter Pankreatitis allerdings unter normal stationären Bedingungen behandelt, sodass ein differenziertes und vor allem kontinuierliches hämodynamisches Monitoring nur begrenzt möglich ist. Neben der Überwachung der Vitalparameter sowie der Messung des zentralen Venendrucks existieren verschiedene andere klinische, laborchemische und bildgebende diagnostische Möglichkeiten, um das Ausmaß des intravasalen Flüssigkeitsdefizits und den individuellen Volumenbedarf eines Patienten mit akuter Pankreatitis orientierend zu ermitteln. Prospektive Studien für ein pankreatitisspezifisches Volumenmanagement fehlen bislang. In dieser Übersicht sollen daher die wichtigsten invasiven und nichtinvasiven diagnostischen Methoden zur Erfassung der zirkulatorischen Hypovolämie bei akuter Pankreatitis aufgezeigt werden.

Abkürzungen

Acute Physiology And Chronic Health Evaluation-II-Score; APACHE-II-Score; akutes Nierenversagen, ANV; Acute Respiratory Distress Syndrome, ARDS; Atrial Natriuretic Peptide (ANP); Brain Natriuretic Peptide (BNP); Bodymass-Index, BMI; Collapsibility Index, CI; C-reaktives Protein, CRP; glomeruläre Filtrationsrate, GFR; Herzfrequenz, Hf; Herzzeitvolumen, HZV; extravasales Lungenwasser, EVLW; Interleukin, Il; intrathorakales Blutvolumen, ITBV; Multiorganversagen, MOV; Pulse Contour Cardiac Output, PCCO; Plättchenaktivierungsfaktor, PAF; Pulmonaliskatheter, PAK; Systemic Inflammatory Response Syndrome, SIRS; transösophageale Echokardiographie, TEE; Tumornekrosefaktor, TNF; Velocity-Time-Integral, VTI; zentraler Venendruck, ZVD, zentraler Venenkatheter, ZVD

Abstract

Severe acute pancreatitis leads to a dramatic fluid loss in the intraperitoneal space which may result in circulatory decompensation. Sequestration of fluid can amount up to 40 percent of the circulating blood volume. The amount of fluid and electrolyte replacement is often misjudged leading to a higher rate of complications and a higher mortality rate of the disease. Furthermore, subsequent and adequate fluid resuscitation seems to influence the prognostic course of the disease by improving the perfusion and oxygenation of the pancreas. Otherwise volume overload may cause cardiopulmonary decompensation in the case of synchronous cardiopulmonary comorbidities. Therefore, an important part of treatment relies on careful haemodynamic monitoring, if necessary managed in an intensive care unit. Usually most patients with acute pancreatitis will be treated on a non-intensive medical ward which allows a differentiated and continuous haemodynamic monitoring only to a limited extent. Apart from monitoring circulatory parameters and measuring central venous pressure, there are other clinical methods, laboratory tests and radiological diagnostic procedures to determine the amount of intravascular fluid deficit and the individual volume demand of patients with acute pancreatitis. Prospective clinical trials for evaluation of pancreatitis-specific volume management do not exist so far. The aim of this review is to provide background information on invasive and non-invasive diagnostic methods for detection of circulatory hypovolemia in acute pancreatitis.

Abbreviations

Acute Physiology And Chronic Health Evaluation-II-Score; APACHE-II-Score; Acute renal failure, ARF; Acute Respiratory Distress Syndrome, ARDS; Atrial Natriuretic Peptide (ANP); Brain Natriuretic Peptide (BNP); Body Mass Index, BMI; Cardiac volume, CV; Central Venous Pressure, CVP; Central Venous Catheter, CVC; Collapsibility Index, CI; C-reaktive Protein, CRP; Glomerular Filtration Rate, GFR; Heart Rate, HR; Extravascular Lung Water, EVLW; Interleucin, Il; Intrathoracic Blood Volume, ITBV; Multiorgan Failure, MOF; Pulse Contour Cardiac Output, PCCO; Platelet-Activating Factor, PAF; Pulmonary Artery Catheter, PAC; Systemic Inflammatory Response Syndrome, SIRS; Transoesophageal Echokardiography, TEE; Tumor-Necrosis Factor, TNF; Velocity-Time-Integral, VTI

Schlüsselwörter

akute Pankreatitis - hämodynamisches Monitoring - Hypovolämie - Volumenmangelschock

Key words

acute pancreatitis - haemodynamic monitoring - hypovolemia - circulatory decompensation

Literatur

• 1 Bourke J, Griggs J, Ebdon D. Variations in the incidence and the spatial distribution of patients with primary acute pancreatitis in Nottingham 1969 - 76.  Gut. 1979;  20 366-371
• 2 Lankisch P G, Assmus C, Maisoneuve P. et al . Epidemiology of pancreatic diseases in Lüneburg County - A study in a defined German population.  Pancreatology. 2002;  2 469-477
• 3 Graham D. Incidence and mortality of acute pancreatitis.  BM J. 1977;  2 1062-1063
• 4 Mössner J, Keim V. Therapy of acute pancreatitis.  Internist. 2003;  44 1508-1514
• 5 Martinez J, Sanchez-Paya J, Palazon J M. et al . Is obesity a risk factor in acute pancreatitis? A metaanalysis.  Pancreatology. 2004;  4 42-48
• 6 Chatzicostas C, Roussomoustakaki M, Vlachonikolis I G. et al . Comparison of Ranson, APACHE I and APACHE III scoring systems in acute pancreatitis.  Pancreas. 2002;  25 331-335
• 7 Larvin M. Assessment of severity and prognosis in acute pancreatitis.  Eur J Gastroenterol Hepatol. 1997;  9 122-130
• 8 Schölmerich J, Heinrich A, Leser H G. Diagnostic approach to acute pancreatitis: diagnosis, assesment of etiology and prognosis.  Hepato-Gastroenterol. 1993;  40 532-537
• 9 UK W orking Party on Acute Pancreatitis. UK guidelines for the management of acute pancreatitis.  Gut. 2005;  54 (Suppl III) 1-9
• 10 Weidenbach H, Lerch M M, Gress T M. et al . Vasoactive mediators and the progression from edematous to necrotizing experimental pancreatitis.  Gut. 1995;  37 434-440
• 11 Rau B, Schilling M K, Beger H G. Laboratory markers of severe acute pancreatitis.  Dig Dis. 2004;  22 247-257
• 12 Lankisch G P, Büchler M W. Akute Pankreatitis. Update: Diagnostik und Therapie 2000.  Deutsches Ärzteblatt, Jg 97. 2000;  Ausgabe 31 - 32 A-2106-2113
• 13 Banks P A. Practical guidelines in acute pancreatitis.  Am J Gastroenterol. 1997;  92 377-386
• 14 Steinberg W, Tenner S. Acute pancreatitis.  N Engl J Med. 1994;  33 1198-1210
• 15 Eckerwall G, Olin H, Andersson B. et al . Fluid resuscitation and nutritional support during severe acute pancreatitis in the past: what have we learned and how can we do better?.  Clin Nutr. 2006;  25 497-504
• 16 Baillargeon J D, Orav J, Ramagopal V. et al . Hemoconcentration as an early risk factor for necrotizing pancreatitis.  Am J Gastroenterol. 1998;  93 2130-2314
• 17 Brown A, Baillargeon J, Hughes M. et al . Can fluid resuscitation prevent pancreatitic necrosis in severe acute pancreatitis?.  Pancreatology. 2002;  2 104-107
• 18 Schölmerich J. Aktuelle Diagnostik der akuten Pankreatitis.  Z Gastroenterol. 1997;  35 (Suppl 1) 63-75
• 19 Reuter D A, Goetz A E. Messung des Herzzeitvolumens.  Anaesthesist. 2005;  54 1135-1153
• 20 Perthig K, Figulla H R. Kardiopulmonales Monitoring bei gastroenterologischen und renalen Notfällen.  Internist. 2005;  46 310-314
• 21 Merril E W. Rheology of blood.  Physiol Rev. 1969;  49 863-888
• 22 Lowe G OD. Blood rheology in vitro and in vivo.  Bailleres Clin Hematol. 1987;  1 587
• 23 Geheb M. Clinical approach to the hyperosmolar patient.  Crit Care Clin. 1987;  5 797-815
• 24 Rose B D. The total body water and the plasma sodium concentration. Clinical physiology of acid-base and electrolyte disorders New York; Mc Graw-Hill 1994 4th ed: 219-234
• 25 Toprak A, Koc M, Tezcan H. et al . Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: an echocardiographic study.  Nephrol Dial Transplant. 2003;  18 2128-2133
• 26 Voga G, Krivec B. Echocardiography in the intensive care unit.  Curr Opin Crit Care. 2000;  6 207-213
• 27 Hosoda K, Nakao K, Mukoyama M. et al . Expression of brain natriuretic peptide gene in human heart. Production in the ventricle.  Hypertension. 1991;  17 1152-1255
• 28 Wiese S, Breyer T, Dragu A. et al . Gene expression of brain natriuretic peptide in isolated aria land ventricular human myocardium: Influence of angiotensin II and diastolic fiber length.  Circulation. 2000;  102 3074-3079
• 29 Nakagawa O, Ogawa Y, Itoh H. et al . Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an „emergency” cardiac hormone against ventricular overload.  J Clin Invest. 1995;  96 1280-1287
• 30 Marcus L S, Hart D, Packer M. et al . Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover-trial.  Circulation. 1996;  94 3184-3189
• 31 Holmes S J, Espiner E A, Richards A M. et al . Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.  J Clin Endocrinol Metab. 1993;  76 91-96
• 32 Lemos J A, McGuire D K, Drazner M H. B-type natriuretic peptide in cardiovascular disease.  Lancet. 2003;  362 316-322
• 33 Doust J A, Glasziou P P, Pietrzak E de. et al . A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.  Arch Intern Med. 2004;  164 1978-1984
• 34 Magga J, Puhakka M, Hietakorpi S. et al . Atrial nariuetic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction.  J Appl Physiol. 2004;  96 1306-1311
• 35 Stein B C, Levin R I. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.  Am Heart J. 1998;  135 (5 pt 1) 914-923
• 36 Maisel A, Krishnaswamy P, Nowak R. et al . Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.  N Engl J Med. 2002;  347 161-167
• 37 Mc Cullough P A, Hollander J E, Nowak R M. et al . Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type Natriuretic Peptide in the emergency department.  Acad Emerg Med. 2003;  10 198-204
• 38 Yamamoto K, Burnett J C Jr, Jougasaki M. et al . Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.  Hypertension. 1996;  28 988-994
• 39 Barclay J L, Kruszewski K, Croal B L. et al . Relation of left atrial volume to B-type natriuretic peptide levels in patients with stable chronic heart failure.  Am J Cardiol. 2006;  98 98-101
• 40 Heringlake M, Heide C, Bahlmann L. et al . Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers.  J Appl Physiol. 2004;  97 173-179
• 41 Tomarus K i K, Aria M, Yokoyama T. et al . Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes.  J Mol Cell Cardiol. 2002;  34 649-659
• 42 He Q, LaPointe M C. Interleukin-1beta regulation of the human brain natriuretic peptide promotor involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes.  Hypertension. 1999;  33 283-289
• 43 Haug C, Metzele A, Steffgen J. et al . Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.  Clin Investig. 1994;  72 430-4
• 44 James K B, Troughton R W, Feldschuh J. et al . Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study.  Am Heart J. 2005;  150 984
• 45 Ishizaka Y, Yamamoto Y, Fukunaga T. et al . Plasma concentration of human brain natriuretic peptide in patients on hemodialysis.  Am J Kidney Dis. 1994;  24 461-72
• 46 Ishibe S, Peixoto A J. Methods of assessment of volume status and intercompartmental fluid shifts in hemodialysis patients: implications in clinical practice.  Semin Dial. 2004;  17 37-43
• 47 Fagugli R M, Palumbo B, Ricciardi D. et al . Association between Brain Natriuretic Peptide and Extracellular Water in Hemodialysis Patients.  Nephron Clinical Practice. 2003;  95 c60-c66
• 48 Crozier J E, McKee R F. Is the landmark technique safe for the insertion of subclavian venous lines?.  Surgeon. 2005;  3 277-305
• 49 Martin M J, Husain F A, Piesman M. et al . Is routine ultrasound guidance for central line placement beneficial? A prospective analysis.  Curr Surg. 2004;  61 71-74
• 50 McGee D, Gould M K. Preventing complications of central venous catheterization.  N Engl J Med. 2003;  348 1123-1133
• 51 Desmond J. Is the central venous pressure reading equally reliable if the central line is inserted via the femoral vein.  Emerg Med J. 2003;  20 467-469
• 52 Swan H J, Ganz W, Forrester J. et al . Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter.  N Engl J Med. 1970;  283 447
• 53 Dummerhill E M, Baram M. Principles of pulmonary artery catheterization in the critically ill.  Lung. 2005;  183 209-219
• 54 Ivanov R, Allen J, Calvin J E. The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: A meta-analysis.  Crit Care Med. 2000;  28 615
• 55 Connors A F Jr, Speroff T, Dawson N V. et al . The effectiveness of right heart catheterization in the initial care of critically ill patients.  JAMA. 1996;  276 889
• 56 Sandham J D, Hull R D, Brant R F. et al . A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.  N Engl J Med. 2003;  348 5
• 57 Sherman S V, Wall M H, Kennedy D J. et al . Do pulmonary artery catheters cause or increase tricuspid or pulmonic valvular regurgitation?.  Anest Analg. 2001;  92 1117-1122
• 58 Harvey S, Harrison D A, Singer M. et al . Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial.  Lancet. 2005;  366 472-477
• 59 Sandham J D, Hull R D, Brant R F. et al . A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.  N Engl J Med. 2003;  348 5-14
• 60 Sakka S G, Ruhl CC, Pfeiffer UJ. et al . Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution.  Intensive Care Med. 2000;  26 180-187
• 61 Della R occa G, Costa M G, Pompei L. et al . Continous and intermittent cardiac output measurement: pulmonary artery catheter versus aortic transpulmonary technique.  Br J Anaesth. 2002;  88 350-356
• 62 Haller M, Zöller C, Briegel J. et al . Evaluation of a new continous thermodilution cardiac output monitor in critically ill patients. A prospective criterion standard study.  Crit Care Med. 1995;  23 860-866
• 63 Felbinger T W, Reuter D A, Eltzschig H K. et al . Cardiac index measurements under rapid preload changes: a comparison of pulmonary artery thermodilution and arterial pulse contour anlysis.  J Clin Anaesth. 2005;  17 241-248
• 64 Sakka S G, Reinhart K, Meier-Hellmann A. Comparison of pulmonary arterial and arterial thermodilution cardiac output in critically ill patients.  Intensive Care Med. 1999;  25 843-846
• 65 Reuter D A, Kirchner A, Felbinger T W. et al . Usefulness of left ventricular stroke volume variation to assess fluid responsiveness in patients with reduced cardiac function.  Crit Care Med. 2003;  31 1399-1404
• 66 Marino P L. Der Pulmonalarterienkatheter. Marino PL, Taeger K Das ICU Buch München; Urban & Fischer 2005 3th ed: 114